Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2-oxopentanedioic acid (Metabolite)

Pubchem:PUBCHEM:51

Id:fea0ae8a-2d75-5205-b7f1-3846e7719cdb

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 2-oxopentanedioic acid's neighborhood in the knowledge graph.

Results found

Linked to

	Label	Description
	IDH3B causally influences 2-oxopentanedioic acid Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	2-oxopentanedioic acid correlated with condition Malignant neoplasm of large intestine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	TAT causally influences 2-oxopentanedioic acid Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	2-oxopentanedioic acid correlated with condition Hyperinsulinemic hypoglycemia, familial, 6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	saliva produces 2-oxopentanedioic acid Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Portion of muscle tissue produces 2-oxopentanedioic acid Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Fibroblasts produces 2-oxopentanedioic acid Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	lung produces 2-oxopentanedioic acid Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Eukaryotic Cells produces 2-oxopentanedioic acid Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Duodenum produces 2-oxopentanedioic acid Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

IDH3B causally influences 2-oxopentanedioic acid

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

2-oxopentanedioic acid correlated with condition Malignant neoplasm of large intestine

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

TAT causally influences 2-oxopentanedioic acid

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

2-oxopentanedioic acid correlated with condition Hyperinsulinemic hypoglycemia, familial, 6

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

saliva produces 2-oxopentanedioic acid

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

Portion of muscle tissue produces 2-oxopentanedioic acid

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

Fibroblasts produces 2-oxopentanedioic acid

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

lung produces 2-oxopentanedioic acid

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

Eukaryotic Cells produces 2-oxopentanedioic acid

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

Knowledge Graph Assertion

Duodenum produces 2-oxopentanedioic acid

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from Metabolomics

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.